ALB and non-small cell lung carcinoma: To identify peripheral blood parameters for prognosis for NSCLC patients treated with nivolumab, 14 continuous variables (albumin, LDH, or blood cell counts, etc.)before ICI treatment along with age, gender, histology, ECOG score, smoking status, and lines of treatment were investigated in all patients (n = 59) by univariate Cox regression analysis (Supplementary Table 1).